158 related articles for article (PubMed ID: 38099064)
1. Construction and evaluation of a prognostic prediction model based on the mEGOS score for patients with Guillain-Barré syndrome.
Xue G; Zhang Y; Wang R; Yang Y; Wang H; Li J; He X; Zhang Q; Yang X
Front Neurol; 2023; 14():1303243. PubMed ID: 38099064
[TBL] [Abstract][Full Text] [Related]
2. Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
Doets AY; Lingsma HF; Walgaard C; Islam B; Papri N; Davidson A; Yamagishi Y; Kusunoki S; Dimachkie MM; Waheed W; Kolb N; Islam Z; Mohammad QD; Harbo T; Sindrup SH; Chavada G; Willison HJ; Casasnovas C; Bateman K; Miller JAL; van den Berg B; Verboon C; Roodbol J; Leonhard SE; Benedetti L; Kuwabara S; Van den Bergh P; Monges S; Marfia GA; Shahrizaila N; Galassi G; Péréon Y; Bürmann J; Kuitwaard K; Kleyweg RP; Marchesoni C; Sedano Tous MJ; Querol L; Illa I; Wang Y; Nobile-Orazio E; Rinaldi S; Schenone A; Pardo J; Vermeij FH; Lehmann HC; Granit V; Cavaletti G; Gutiérrez-Gutiérrez G; Barroso FA; Visser LH; Katzberg HD; Dardiotis E; Attarian S; van der Kooi AJ; Eftimov F; Wirtz PW; Samijn JPA; Gilhuis HJ; Hadden RDM; Holt JKL; Sheikh KA; Karafiath S; Vytopil M; Antonini G; Feasby TE; Faber CG; Gijsbers CJ; Busby M; Roberts RC; Silvestri NJ; Fazio R; van Dijk GW; Garssen MPJ; Straathof CSM; Gorson KC; Jacobs BC;
Neurology; 2022 Feb; 98(5):e518-e532. PubMed ID: 34937789
[TBL] [Abstract][Full Text] [Related]
3. The utility of Guillain-Barré syndrome prognostic models in Malaysian patients.
Tan CY; Razali SNO; Goh KJ; Shahrizaila N
J Peripher Nerv Syst; 2019 Jun; 24(2):168-173. PubMed ID: 31001904
[TBL] [Abstract][Full Text] [Related]
4. Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré Syndrome.
Yao J; Zhou R; Liu Y; Liu Y; Cao Q; Lu Z
Neurol Ther; 2023 Dec; 12(6):2121-2132. PubMed ID: 37792219
[TBL] [Abstract][Full Text] [Related]
5. Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh.
Papri N; Doets AY; Mohammad QD; Endtz HP; Lingsma HF; Jacobs BC; Islam Z
Ann Clin Transl Neurol; 2022 Aug; 9(8):1264-1275. PubMed ID: 35908170
[TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of prognostic indicators for Guillain-Barré syndrome in children.
Qinrong H; Yuxia C; Ling L; Huayu L; Lei X; Xiaoli L; Nong X
Dev Med Child Neurol; 2023 Apr; 65(4):563-570. PubMed ID: 36175376
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a single-center-based early prognostic scoring system for Guillain-Barré syndrome.
Di X; Wang J; Li L; Liu L
BMC Neurol; 2023 Mar; 23(1):97. PubMed ID: 36870949
[TBL] [Abstract][Full Text] [Related]
8. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.
Yamagishi Y; Kuwahara M; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida KI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1339-1342. PubMed ID: 33041261
[TBL] [Abstract][Full Text] [Related]
9. [The prognosis and prognostic factor of Guillain-Barré Syndrome].
Yamagishi Y; Kusunoki S
Rinsho Shinkeigaku; 2020 Apr; 60(4):247-252. PubMed ID: 32238748
[TBL] [Abstract][Full Text] [Related]
10. Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study.
Yamagishi Y; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida K; Ikeda SI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
J Peripher Nerv Syst; 2017 Dec; 22(4):433-439. PubMed ID: 28833828
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome from an emergency department view: how to better predict the outcome?
Covino M; Romozzi M; Simeoni B; Di Paolantonio A; Sabatelli M; Franceschi F; Luigetti M
Neurol Res; 2022 Nov; 44(11):964-968. PubMed ID: 35580194
[TBL] [Abstract][Full Text] [Related]
12. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
Eur J Neurol; 2023 Dec; 30(12):3646-3674. PubMed ID: 37814552
[TBL] [Abstract][Full Text] [Related]
13. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
J Peripher Nerv Syst; 2023 Dec; 28(4):535-563. PubMed ID: 37814551
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin treatment with prognosis for the first six months of Guillain-Barré Syndrome in Somalia: Case series.
Sidow NO; Hassan MS
Ann Med Surg (Lond); 2022 Dec; 84():104816. PubMed ID: 36536744
[TBL] [Abstract][Full Text] [Related]
15. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
[TBL] [Abstract][Full Text] [Related]
16. The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.
Kong L; Wu X; Cheng Y; Liu S; Liu K; Li C
Neurol Sci; 2022 Aug; 43(8):5017-5028. PubMed ID: 35469074
[TBL] [Abstract][Full Text] [Related]
17. A clinical prognostic scoring system for Guillain-Barré syndrome.
van Koningsveld R; Steyerberg EW; Hughes RA; Swan AV; van Doorn PA; Jacobs BC
Lancet Neurol; 2007 Jul; 6(7):589-94. PubMed ID: 17537676
[TBL] [Abstract][Full Text] [Related]
18. Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.
van Tilburg SJ; Teunissen CE; Maas CCHM; Thomma RCM; Walgaard C; Heijst H; Huizinga R; van Doorn PA; Jacobs BC
EBioMedicine; 2024 Apr; 102():105072. PubMed ID: 38518653
[TBL] [Abstract][Full Text] [Related]
19. Early recognition of poor prognosis in Guillain-Barre syndrome.
Walgaard C; Lingsma HF; Ruts L; van Doorn PA; Steyerberg EW; Jacobs BC
Neurology; 2011 Mar; 76(11):968-75. PubMed ID: 21403108
[TBL] [Abstract][Full Text] [Related]
20. A novel prognostic system based on clinical and laboratory parameters for childhood Guillain-Barre syndrome.
Tiwari I; Alam A; Kanta C; Koonwar S; Garg RK; Pandey S; Jain A; Kumar R
Acta Neurol Belg; 2022 Oct; 122(5):1237-1245. PubMed ID: 35753018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
